Terms: = Bone cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Treatment
35 results:
1. Characterizing the presentation, management, and clinical outcomes of patients with intradural spinal chordomas: a systematic review.
Saint-Germain MA; Kramer P; Weber-Levine C; Jiang K; Al-Mistarehi AH; Redmond KJ; Lee SH; Bettegowda C; Theodore N; Lubelski D
Neurosurg Focus; 2024 May; 56(5):E14. PubMed ID: 38691865
[TBL] [Abstract] [Full Text] [Related]
2. Cross-Disciplinary Approach of Adrenal Tumors: Insights into Primary Aldosteronism-Related Mineral Metabolism Status and Osteoporotic Fracture Risk.
Trandafir AI; Gheorghe AM; Sima OC; Ciuche A; Petrova E; Nistor C; Carsote M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139166
[TBL] [Abstract] [Full Text] [Related]
3. Prospective Evaluation of the Clinical Benefits of a Novel Tattoo-less Workflow for Nonspine bone Stereotactic Body Radiation Therapy: Integrating Surface-Guidance With Triggered Imaging Reduces treatment Time and Eliminates the Need for Tattoos.
Zhou AZ; Conway L; Bartlett S; Marques A; Physic M; Czerminska M; Spektor A; Killoran JH; Friesen S; Bredfeldt J; Huynh MA
Pract Radiat Oncol; 2024; 14(2):93-102. PubMed ID: 37944748
[TBL] [Abstract] [Full Text] [Related]
4. PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma.
Haas M; Caron G; Chatonnet F; Manenti S; Alaterre E; Devin J; Delaloy C; Bertolin G; Viel R; Pignarre A; Llamas-Gutierrez F; Marchalot A; Decaux O; Tarte K; Delpy L; Moreaux J; Fest T
Blood; 2022 Apr; 139(15):2316-2337. PubMed ID: 35108359
[TBL] [Abstract] [Full Text] [Related]
5. Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells.
Muscella A; Stefàno E; De Bellis L; Nutricati E; Negro C; Marsigliante S
Ann N Y Acad Sci; 2021 Sep; 1500(1):34-47. PubMed ID: 33960434
[TBL] [Abstract] [Full Text] [Related]
6. Steroid resistance in Diamond Blackfan anemia associates with p57Kip2 dysregulation in erythroid progenitors.
Ashley RJ; Yan H; Wang N; Hale J; Dulmovits BM; Papoin J; Olive ME; Udeshi ND; Carr SA; Vlachos A; Lipton JM; Da Costa L; Hillyer C; Kinet S; Taylor N; Mohandas N; Narla A; Blanc L
J Clin Invest; 2020 Apr; 130(4):2097-2110. PubMed ID: 31961825
[TBL] [Abstract] [Full Text] [Related]
7. Antitumor effect of baicalin from the Scutellaria baicalensis radix extract in B-acute lymphoblastic leukemia with different chromosomal rearrangements.
Orzechowska BU; Wróbel G; Turlej E; Jatczak B; Sochocka M; Chaber R
Int Immunopharmacol; 2020 Feb; 79():106114. PubMed ID: 31881375
[TBL] [Abstract] [Full Text] [Related]
8. Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models.
Stefka AT; Johnson D; Rosebeck S; Park JH; Nakamura Y; Jakubowiak AJ
Cancer Med; 2020 Jan; 9(1):324-334. PubMed ID: 31714026
[TBL] [Abstract] [Full Text] [Related]
9. p27/kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma.
Currier AW; Kolb EA; Gorlick RG; Roth ME; Gopalakrishnan V; Sampson VB
Sci Rep; 2019 Apr; 9(1):6161. PubMed ID: 30992462
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-221 regulates osteosarcoma cell proliferation, apoptosis, migration, and invasion by targeting cdkn1b/p27.
Hu XH; Zhao ZX; Dai J; Geng DC; Xu YZ
J Cell Biochem; 2019 Mar; 120(3):4665-4674. PubMed ID: 30582227
[TBL] [Abstract] [Full Text] [Related]
11. BMP4 enhances hepatocellular carcinoma proliferation by promoting cell cycle progression via ID2/cdkn1b signaling.
Ma J; Zeng S; Zhang Y; Deng G; Qu Y; Guo C; Yin L; Han Y; Shen H
Mol Carcinog; 2017 Oct; 56(10):2279-2289. PubMed ID: 28543546
[TBL] [Abstract] [Full Text] [Related]
12. The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling.
Zhang HT; Gui T; Sang Y; Yang J; Li YH; Liang GH; Li T; He QY; Zha ZG
J Cell Biochem; 2017 Aug; 118(8):2182-2192. PubMed ID: 28059436
[TBL] [Abstract] [Full Text] [Related]
13. Silencing of NUF2 inhibits proliferation of human osteosarcoma Saos-2 cells.
Fu HL; Shao L
Eur Rev Med Pharmacol Sci; 2016; 20(6):1071-9. PubMed ID: 27049259
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.
Sun H; Lin DC; Guo X; Kharabi Masouleh B; Gery S; Cao Q; Alkan S; Ikezoe T; Akiba C; Paquette R; Chien W; Müller-Tidow C; Jing Y; Agelopoulos K; Müschen M; Koeffler HP
Oncotarget; 2016 Apr; 7(14):18736-49. PubMed ID: 26934650
[TBL] [Abstract] [Full Text] [Related]
15. 15,16-dihydrotanshinone I Induces Apoptosis and Inhibits the Proliferation, Migration of Human Osteosarcoma Cell Line 143B in vitro.
Chen X; Li Q; He Y; Du H; Zhan Z; Zhao H; Shi J; Ye Q; Hu J
Anticancer Agents Med Chem; 2017; 17(9):1234-1242. PubMed ID: 26478521
[TBL] [Abstract] [Full Text] [Related]
16. Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer.
Mehta A; Zhang L; Boufraqech M; Zhang Y; Patel D; Shen M; Kebebew E
Endocr Relat Cancer; 2015 Jun; 22(3):319-29. PubMed ID: 25972243
[TBL] [Abstract] [Full Text] [Related]
17. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.
Mitsui Y; Hirata H; Arichi N; Hiraki M; Yasumoto H; Chang I; Fukuhara S; Yamamura S; Shahryari V; Deng G; Saini S; Majid S; Dahiya R; Tanaka Y; Shiina H
Oncotarget; 2015 Apr; 6(11):9577-91. PubMed ID: 25797254
[TBL] [Abstract] [Full Text] [Related]
18. Matrine inhibits the growth and induces apoptosis of osteosarcoma cells in vitro by inactivating the Akt pathway.
Xu GP; Zhao W; Zhuang JP; Zu JN; Wang DY; Han F; Zhang ZP; Yan JL
Tumour Biol; 2015 Mar; 36(3):1653-9. PubMed ID: 25371071
[TBL] [Abstract] [Full Text] [Related]
19. CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy.
Ding L; Chen S; Liu P; Pan Y; Zhong J; Regan KM; Wang L; Yu C; Rizzardi A; Cheng L; Zhang J; Schmechel SC; Cheville JC; Van Deursen J; Tindall DJ; Huang H
Cancer Res; 2014 Apr; 74(7):2050-61. PubMed ID: 24491799
[TBL] [Abstract] [Full Text] [Related]
20. [Nuclear medicine in radiotherapy planning for patients with malignant neoplasms of different locations].
Kanaev SV; Novikov SN; Girshovich MM; Krivorot'ko PV; Beĭnusov DS; Krzhivitskiĭ PI
Vopr Onkol; 2012; 58(2):189-93. PubMed ID: 22774522
[TBL] [Abstract] [Full Text] [Related]
[Next]
